↓ Skip to main content

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

Overview of attention for article published in Drugs, February 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 3,466)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Citations

dimensions_citation
283 Dimensions

Readers on

mendeley
496 Mendeley
Title
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
Published in
Drugs, February 2019
DOI 10.1007/s40265-019-1055-2
Pubmed ID
Authors

George G. Zhanel, Alyssa R. Golden, Sheryl Zelenitsky, Karyn Wiebe, Courtney K. Lawrence, Heather J. Adam, Temilolu Idowu, Ronald Domalaon, Frank Schweizer, Michael A. Zhanel, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Ayman Noreddin, Joseph P. Lynch III, James A. Karlowsky

X Demographics

X Demographics

The data shown below were collected from the profiles of 67 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 496 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 496 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 61 12%
Student > Bachelor 54 11%
Student > Master 52 10%
Researcher 46 9%
Other 28 6%
Other 82 17%
Unknown 173 35%
Readers by discipline Count As %
Medicine and Dentistry 80 16%
Pharmacology, Toxicology and Pharmaceutical Science 48 10%
Immunology and Microbiology 44 9%
Chemistry 44 9%
Biochemistry, Genetics and Molecular Biology 42 8%
Other 52 10%
Unknown 186 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 73. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#586,836
of 25,387,668 outputs
Outputs from Drugs
#47
of 3,466 outputs
Outputs of similar age
#13,721
of 447,223 outputs
Outputs of similar age from Drugs
#4
of 48 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,466 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.